Cargando…

Anticytokine therapy for periodontal diseases: Where are we now?

Periodontal destruction is initiated by bacteria that stimulate host responses leading to excess production of cytokines. Anticytokine therapy for periodontal diseases especially targets proinflammatory cytokines, that is, TNF-α, IL-1, and IL-6, because these are essential for the initiation of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waykole, Yogesh Prakash, Doiphode, S. S., Rakhewar, P. S., Mhaske, Maya
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847126/ https://www.ncbi.nlm.nih.gov/pubmed/20407652 http://dx.doi.org/10.4103/0972-124X.55837

Ejemplares similares

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Synthetic Material for Bone, Periodontal, and Dental Tissue Regeneration: Where Are We Now, and Where Are We Heading Next?
por: Cheah, Chia Wei, et al.
Publicado: (2021)

Anticytokine Autoantibodies and Fungal Infections
por: Kappagoda, Shanthi, et al.
Publicado: (2023)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Update on Anticytokine Treatment for Asthma
por: Gallelli, Luca, et al.
Publicado: (2013)

Clinical Review: Gene-based therapies for ALI/ARDS: where are we now?
por: Devaney, James, et al.
Publicado: (2011)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Viral Anticytokine Strategies
por: Alcami, Antonio
Publicado: (2016)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Prime Editing for Human Gene Therapy: Where Are We Now?
por: Godbout, Kelly, et al.
Publicado: (2023)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Where are we now?
Publicado: (1977)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?
por: Gazerani, Parisa
Publicado: (2020)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Microbiota and Obesity: Where Are We Now?
por: Ballini, Andrea, et al.
Publicado: (2020)

Osteopontin and Transplantation: Where Are We Now?
por: Kaleta, Beata
Publicado: (2021)

Genetics of migraine: where are we now?
por: Grangeon, Lou, et al.
Publicado: (2023)

Hormone Therapy and Risk of Breast Cancer: Where Are We Now?
por: Micha, John P., et al.
Publicado: (2022)

Vitamin E: Where Are We Now in Vascular Diseases?
por: Garg, Anahita, et al.
Publicado: (2022)

Treatment of uveal melanoma: where are we now?
por: Yang, Jessica, et al.
Publicado: (2018)

Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
por: Hilmi, Marc, et al.
Publicado: (2018)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Liposomes in Cancer Therapy: How Did We Start and Where Are We Now
por: Fulton, Melody D., et al.
Publicado: (2023)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
por: Daliri, Karim, et al.
Publicado: (2017)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Cardiovascular Tissue Engineering: Where We Come From and Where Are We Now?
por: Smit, Francis E., et al.
Publicado: (2015)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
por: AHMED, MOHAMED H
Publicado: (2018)

Future Perspectives in Pediatric Dentistry: Where are We Now and where are We Heading?
por: Rodrigues, Jonas A, et al.
Publicado: (2022)

Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011)

Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
por: Knight, Vijaya, et al.
Publicado: (2016)

Pioglitazone in Clinical Practice: Where Are We Now?
por: Govindan, Joytish, et al.
Publicado: (2012)

Hepatitis C treatment: where are we now?
por: Burstow, Nicholas J, et al.
Publicado: (2017)

Pediatric SJS-TEN: Where are we now?
por: Ramien, Michele, et al.
Publicado: (2020)

Retinal Organoid Technology: Where Are We Now?
por: Zhang, Zuming, et al.
Publicado: (2021)

Exercise stress echocardiography: Where are we now?
por: Cotrim, Carlos Alberto, et al.
Publicado: (2022)

Metformin and Breast Cancer: Where Are We Now?
por: Cejuela, Mónica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iggi5fktrgp1fii65simm8m5r8